Cita APA

Moreno-Garcia, M., Castellano-Herrador, J., Madrid-Gonzalez, M., Ramis-Riera, X., Santos-Pérez, M., Prada-Lobato, J., & Rodriguez-Barbero, J. (2018). 4CPS-084 Identification of patient candidates to switch from tenofovir/emtricitabine to abacavir/lamivudine antiretroviral therapy: Economic saving. Eur J Hosp Pharm.

Citación estilo Chicago

Moreno-Garcia, M., JJ Castellano-Herrador, M. Madrid-Gonzalez, X. Ramis-Riera, M. Santos-Pérez, J. Prada-Lobato, y J. Rodriguez-Barbero. "4CPS-084 Identification of Patient Candidates to Switch From Tenofovir/emtricitabine to Abacavir/lamivudine Antiretroviral Therapy: Economic Saving." Eur J Hosp Pharm 2018.

Cita MLA

Moreno-Garcia, M., et al. "4CPS-084 Identification of Patient Candidates to Switch From Tenofovir/emtricitabine to Abacavir/lamivudine Antiretroviral Therapy: Economic Saving." Eur J Hosp Pharm 2018.